Illuminating the “Dark Space”: Adapting Patient Experience Metrics to Modern Pathology and Cytology

Export Citation CrossMark Publons Harvard Library HOLLIS GrowKudos Search IT Google Scholar Academic Microsoft Scilit Semantic Scholar Universite de Paris UW Libraries SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat DTU VU on WorldCat ResearchGate

In the paradigm of value-based healthcare, measuring patient experience has evolved from a peripheral administrative task into a core ethical and strategic imperative [1]. While clinical outcomes remain the gold standard, the psychological and logistical journey of the patient heavily dictates their perception of care quality. Regrettably, departments operating in the “dark space” of medicine-those without routine bedside presence, such as Anatomic Pathology-are systematically excluded from this discourse. Pathology and Cytology are often misconstrued as detached, purely analytical factories. Yet, behind every biopsy cassette and cytology smear lies a patient experiencing acute vulnerability. The efficiency, accessibility, and clarity of our cellular diagnoses profoundly shape the patient’s emotional and clinical trajectory [2].

To humanize these silent disciplines, we propose a disruptive framework: integrating three rigorous operational metrics—traditionally confined to corporate management—directly into the quality ecosystem of pathology laboratories [3]:

• Customer Satisfaction Score (CSAT): This metric must evaluate localized, transactional touch points. This is uniquely critical in Cytology, where the clinician-pathologist often performs direct clinical interventions. CSAT should be deployed to measure the experience in Fine-Needle Aspiration (FNA) clinics, auditing everything from pre-biopsy anxiety reduction to the physical comfort during rapid on-site evaluation (ROSE). For instance, implementing a brief, post-procedural digital CSAT survey in an FNA clinic allows patients to rate the empathetic communication of the cytologist, translating a cold diagnostic procedure into a measurable human encounter.
• Customer Effort Score (CES): This serves as our primary tool to detect operational friction. In pathology, administrative bureaucracy is a source of secondary trauma. When a patient requires their histological slides, paraffin blocks, or archival cytology smears for a multi-disciplinary tumor board or a second opinion at another institution, how many hurdles do they face? High friction in specimen logistics correlates with severe patient distress. Incorporating CES forces departments to streamline slide-release protocols and embrace secure digital pathology pathways for patient-led consultation [4]. A real-world application involves tracking the days and steps required for a patient to transfer material; a low CES score would trigger the automated digitization and cloud-sharing of the specimen.
• Net Promoter Score (NPS): While patients rarely choose their pathologist, the institutional NPS—reflecting systemic loyalty and brand advocacy—is heavily contingent on our turnaround times (TAT). The agonizing wait for a cytological screening or a malignant biopsy report represents a period of intense “diagnostic toxicity.” For example, a department that systematically reduces its breast core biopsy TAT from seven days to 48 hours, or provides patient-accessible, plain-language summaries alongside the formal synoptic report, directly mitigates patient anxiety and drives a positive institutional NPS.

Implementation Challenges and Limitations: Realizing this framework requires overcoming distinct operational barriers. First, financial constraints and increased staff workload associated with deploying and monitoring survey infrastructures can strain laboratory resources. Second, since patients have limited direct interaction with most pathologists, evaluating their performance requires creative touch points—such as embedding feedback links directly into patient portals or patient-centered pathology reports.

1. Porter ME. What is the value in health care? N Engl J Med. 2010;363(26):2477-81. Available from: https://doi.org/10.1056/nejmp1011024
2. Larsson LG. Patient experience in the dark spaces of medicine: The unaddressed psychological burden of diagnostic waiting times. J Clin Pathol. 2022;75(4):211-6.
3. Black N. Patient-reported outcome measures could help transform healthcare. BMJ. 2013;346:f167. Available from: https://doi.org/10.1136/bmj.f167
4. Hanna MG. Digital pathology and patient-centered care: Streamlining second opinions and specimen logistics. Arch Pathol Lab Med. 2024;148(2):185-92.